These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 854139)

  • 21. Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis.
    Chan KE; Edelman ER; Wenger JB; Thadhani RI; Maddux FW
    Circulation; 2015 Mar; 131(11):972-9. PubMed ID: 25595139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The safety of heparins in end-stage renal disease.
    Sonawane S; Kasbekar N; Berns JS
    Semin Dial; 2006; 19(4):305-10. PubMed ID: 16893408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased blood loss from access cannulation site during hemodialysis is associated with anemia and arteriovenous graft use.
    Lin CL; Chen HY; Huang SC; Hsu SP; Pai MF; Peng YS; Chiu YL
    Ther Apher Dial; 2014 Feb; 18(1):51-6. PubMed ID: 24499084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clotting by heparin of hemoaccess for hemodialysis in an end-stage renal disease patient.
    Pham PT; Miller JM; Demetrion G; Lew SQ
    Am J Kidney Dis; 1995 Apr; 25(4):642-7. PubMed ID: 7702065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of oral anticoagulation on clotting during hemodialysis.
    Ziai F; Benesch T; Kodras K; Neumann I; Dimopoulos-Xicki L; Haas M
    Kidney Int; 2005 Aug; 68(2):862-6. PubMed ID: 16014067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical usefulness of heparin-coated dialyzers].
    Kopeć J; Sułowicz W
    Przegl Lek; 2014; 71(8):430-2. PubMed ID: 25546914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin free dialysis: comparative data and results in high risk patients.
    Caruana RJ; Raja RM; Bush JV; Kramer MS; Goldstein SJ
    Kidney Int; 1987 Jun; 31(6):1351-5. PubMed ID: 3613407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A hemodialysis cohort study of protocol-based anticoagulation management.
    Lamontagne S; Basein T; Chang B; Mallela L
    BMC Res Notes; 2017 Jan; 10(1):66. PubMed ID: 28126020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anticoagulation of the extracorporeal circuit in chronic hemodialysis].
    Ryckelynck JP; Chouraqui D; Lobbedez T
    Nephrologie; 1998; 19(4):223-5. PubMed ID: 9675763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laparoscopic renal-adrenal surgery in patients on oral anticoagulant therapy.
    Varkarakis IM; Rais-Bahrami S; Allaf ME; Lima GC; Permpongkosol S; Rao P; Jarrett TW; Kavoussi LR
    J Urol; 2005 Sep; 174(3):1020-3; discussion 1023. PubMed ID: 16094036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Renal replacement therapy by hemodialysis: an overview].
    Jacobs C
    Nephrol Ther; 2009 Jul; 5(4):306-12. PubMed ID: 19481513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Warfarin use and incidence of stroke in Japanese hemodialysis patients with atrial fibrillation.
    Yodogawa K; Mii A; Fukui M; Iwasaki YK; Hayashi M; Kaneko T; Miyauchi Y; Tsuruoka S; Shimizu W
    Heart Vessels; 2016 Oct; 31(10):1676-80. PubMed ID: 26646256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of citrate-enriched bicarbonate based dialysate on anticoagulation and dialyzer reuse in maintenance hemodialysis patients.
    Rocha AD; Padua VC; Oliveira E; Guimaraes MM; Lugon JR; Strogoff de Matos JP
    Hemodial Int; 2014 Apr; 18(2):467-72. PubMed ID: 24261328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent.
    Zusman RM; Rubin RH; Cato AE; Cocchetto DM; Crow JW; Tolkoff-Rubin N
    N Engl J Med; 1981 Apr; 304(16):934-9. PubMed ID: 7010166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of anticoagulation on blood membrane interactions during hemodialysis.
    Hofbauer R; Moser D; Frass M; Oberbauer R; Kaye AD; Wagner O; Kapiotis S; Druml W
    Kidney Int; 1999 Oct; 56(4):1578-83. PubMed ID: 10504511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodialysis without heparin infusion using Cordis Dow 3500 hollow fiber.
    Raja R; Kramer M; Rosenbaum JL; Bolisay C; Krug M
    Proc Clin Dial Transplant Forum; 1980; 10():39-42. PubMed ID: 7346852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case report of recurrent vascular access thrombosis in a hemodialysis patient reveals combined acquired and inherited thrombophilia.
    Eleftheriadis T; Antoniadi G; Akritidou A; Kasimatis E; Apostolidis G; Pashalidou S; Salmas M; Liakopoulos V; Barboutis K
    Ther Apher Dial; 2008 Apr; 12(2):190-2. PubMed ID: 18387172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic anticoagulation and bleeding in children with hemodialysis catheters.
    Moritz ML; Vats A; Ellis D
    Pediatr Nephrol; 2003 Jan; 18(1):68-70. PubMed ID: 12488995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatal Dialysis Vascular Access Hemorrhage.
    Jose MD; Marshall MR; Read G; Lioufas N; Ling J; Snelling P; Polkinghorne KR
    Am J Kidney Dis; 2017 Oct; 70(4):570-575. PubMed ID: 28673467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.